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By drug dilution tests in agar, it has been shown that each of 27 strains of
Nocardia asteroides was inhibited by 1 ,ug or less of amikacin per ml of
medium.
Human infection with Nocardia species is
not uncommon; 500 to 1000 cases are recognized
in the United States each year (2). N. aster-
oides accounts for the majority of these sys-
temic infections (2). The sulfonamides have
been the accepted chemotherapy for Nocardia
infections, but alternatives are necessary for
patients who are allergic to the sulfonamides
or in those instances in which sulfonamide
treatment fails. We, therefore, decided to test
the susceptibility ofN. asteroides, an acid-fast
organism, to amikacin, because in an earlier
study we had demonstrated that 18 strains of
Mycobacterium fortuitum and 13 strains of M.
chelonei, also acid-fast organisms, were suscep-
tible to amikacin (J. R. Dalovisio and G. A.
Pankey, J. Infect. Dis., in press).
We obtained 27 strains of N. asteroides on
agar slants from stock cultures of Donald
Schneidau (Division of Mycology, Tulane Uni-
versity School of Medicine, New Orleans, La.).
The method for preparation of homogeneous
suspensions ofNocardia was adapted from that
of Bach et al (1). A loopful of Nocardia taken
from the agar slant was transferred into a
screw-cap tube containing 4 ml of Mueller-Hin-
ton broth (Difco, Detroit, Mich.) and a sterile
glass bead. This was incubated on a rotary
shaker at 3700. After 24 h of incubation, the
tubes were shaken for 5 min on a Vortex mixer
(Lab-Line Instruments, Melrose Park, Ill.).
After 48 h of incubation, 1 ml of this microbial
suspension was transferred to another screw-
top tube containing 4 ml of Mueller-Hinton
broth and a sterile glass bead. This was incu-
bated at 3700 for 4 days with intermittent
agitation for 5 min every 24 h on the Vortex
mixer.
At the end of this period of incubation the
cultures yielded homogeneous suspensions of
N. asteroides with varying degrees of turbidity.
The cultures showing marked turbidity were
diluted 1:100, and those showing moderate tur-
bidity were diluted 1:10 in Mueller-Hinton
broth. Cultures showing no turbidity were used
undiluted in the wells of a Steers inocula repli-
cator (Melrose Machine Shop, Woodlyn, Pa.).
Susceptibility testing was performed with a
Steers inocula replicator on serial twofold dilu-
tions of amikacin (from 0.25 to 64.0 gg/ml) in
Mueller-Hinton agar (BBL, Div. of Beckton-
Dickinson & Co., Cockeysville, Md.) (5). A
plate containing no antibiotic was also inocu-
lated. The minimal inhibitory concentration
(MIC) was considered to be the lowest concen-
tration of amikacin that produced no growth
visible under a hand lens after 48 h of incuba-
tion at 37°C. Suspensions of American Type
Culture Collection (ATCC) strains of Staphylo-
coccus aureus 25923, Escherichia coli 25922,
and Pseudomonas aeruginosa 27853 at a 1:20
dilution of a %/2 McFarland no. 1 nephelometer
standard were used as controls. Normal agar
dilution control values for the amikacin MICs
of these three strains were 1 ,ug/ml, 2 ,ug/ml,
and 2 ,ug/ml, respectively. These values were
obtained from Bristol Laboratories, Syracuse,
N.Y. To provide control of the inoculum
strength of the Nocardia suspension, serial
dilutions of these suspensions were made and
plated with a 0.001-ml calibrated wire loop
onto blood agar plates. Only those suspensions
yielding 107 to 109 colony-forming units per ml
were included in these data.
These organisms were also tested by a modi-
fied Bauer-Kirby disk diffusion technique. The
suspension of organisms adjusted to 107 to 109
CFU/ml was swabbed with a cotton-tipped
swab onto a petri dish of Mueller-Hinton agar
of 5 mm depth. Amikacin disks of 10-,ug
strength (BBL) were placed on the agar sur-
face, and plates were incubated at 370C. The
diameter of the zone of inhibition was mea-
sured after 48 h.
Amikacin showed good activity against all
27 strains of N. asteroides tested (Fig. 1): 44%
were inhibited by concentrations s0.25 jig/ml,
and 100% of strains tested were inhibited by 1
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It has been suggested that, in certain in-
stances, there is poor correlation between in
vitro susceptibility tests and the in vivo re-
sponse of Nocardia infection to antimicrobial
agents (3). Although our in vitro data suggest
that amikacin may be useful in the treatment
ofN. asteroides infections, in vivo confirmation
by animal studies is essential before amikacin
should be considered for treatment of human
infections with N. asteroides.
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FIG. 1. Bauer-Kirby zone diameter and corre-
sponding agar dilution MICs for 27 strains of N.
asteroides.
,ug of amikacin per ml. These findings confirm
two previous reports that amikacin is active in
vitro against N. asteroides (1, 4). The diame-
ters of the zones of inhibition that we measured
correlated well with the zone diameters of those
organisms with comparable MICs tested by
Wallace et al. (4). Since none of the strains of
N. asteroides that we tested required MICs in
the intermediate or resistant range, it is not
possible to tell if Bauer-Kirby disk testing
would discriminate between susceptible and
resistant organisms.
Lea Seeger and Cathy Dickinson provided technical
advice and assistance.
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